Atricure Stock Current Liabilities
| ATRC Stock | USD 37.74 1.57 4.34% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess AtriCure's long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. AtriCure Company Current Liabilities Analysis
AtriCure's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current AtriCure Current Liabilities | 31.59 M |
Most of AtriCure's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AtriCure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, AtriCure has a Current Liabilities of 31.59 M. This is 98.2% lower than that of the Health Care Equipment & Supplies sector and 94.34% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.6% higher than that of the company.
Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
AtriCure Fundamentals
| Return On Equity | -0.0611 | |||
| Return On Asset | -0.0265 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 1.73 B | |||
| Shares Outstanding | 49.72 M | |||
| Shares Owned By Insiders | 3.21 % | |||
| Shares Owned By Institutions | 96.79 % | |||
| Number Of Shares Shorted | 2.3 M | |||
| Price To Earning | 33.47 X | |||
| Price To Book | 3.77 X | |||
| Price To Sales | 3.47 X | |||
| Revenue | 465.31 M | |||
| Gross Profit | 388.06 M | |||
| EBITDA | (18.53 M) | |||
| Net Income | (44.7 M) | |||
| Cash And Equivalents | 118.45 M | |||
| Cash Per Share | 2.55 X | |||
| Total Debt | 76.53 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 3.66 X | |||
| Book Value Per Share | 9.59 X | |||
| Cash Flow From Operations | 12.2 M | |||
| Short Ratio | 4.79 X | |||
| Earnings Per Share | (0.61) X | |||
| Price To Earnings To Growth | (1.18) X | |||
| Target Price | 51.67 | |||
| Number Of Employees | 1.3 K | |||
| Beta | 1.48 | |||
| Market Capitalization | 1.8 B | |||
| Total Asset | 609.33 M | |||
| Retained Earnings | (401.75 M) | |||
| Working Capital | 194.4 M | |||
| Current Asset | 74.75 M | |||
| Current Liabilities | 31.59 M | |||
| Net Asset | 609.33 M |
About AtriCure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AtriCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AtriCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AtriCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out AtriCure Piotroski F Score and AtriCure Altman Z Score analysis. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.